BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hung Y, Lee J, Tsai B, Wu J, Liu H, Liu H, Lin H, Tsai P, Ko W. Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration. Journal of Microbiology, Immunology and Infection 2021;54:276-83. [DOI: 10.1016/j.jmii.2019.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Tsai B, Lai Y, Chiu C, Hsu C, Chen Y, Chen Y, Tsai P, Hung Y, Ko W. Effect of Doxycycline in Decreasing the Severity of Clostridioides difficile Infection in Mice. Antibiotics 2022;11:116. [DOI: 10.3390/antibiotics11010116] [Reference Citation Analysis]
2 Chiu CW, Tsai PJ, Lee CC, Ko WC, Hung YP. Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents. Pathogens 2021;10:649. [PMID: 34073695 DOI: 10.3390/pathogens10060649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tsai CS, Hung YP, Lee JC, Syue LS, Hsueh PR, Ko WC. Clostridioides difficile infection: an emerging zoonosis? Expert Rev Anti Infect Ther 2021;:1-10. [PMID: 34383624 DOI: 10.1080/14787210.2021.1967746] [Reference Citation Analysis]
4 Al-Tawfiq JA, Rabaan AA, Bazzi AM, Raza S, Noureen M. Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia. Am J Infect Control 2020;48:1152-7. [PMID: 32122671 DOI: 10.1016/j.ajic.2020.01.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Hung YP, Tsai CS, Tsai BY, Tsai PJ, Lee YT, Lee JC, Liu HC, Hsueh PR, Lee CC, Ko WC. Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan. J Microbiol Immunol Infect 2021:S1684-1182(21)00045-1. [PMID: 33678554 DOI: 10.1016/j.jmii.2021.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Brajerova M, Zikova J, Krutova M. Clostridioides difficile epidemiology in the Middle and the Far East. Anaerobe 2022;:102542. [PMID: 35240336 DOI: 10.1016/j.anaerobe.2022.102542] [Reference Citation Analysis]
7 Lee CC, Lee JC, Chiu CW, Tsai PJ, Ko WC, Hung YP. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection. Microbiol Spectr 2021;9:e0079921. [PMID: 34668727 DOI: 10.1128/Spectrum.00799-21] [Reference Citation Analysis]
8 Lai YH, Tsai BY, Hsu CY, Chen YH, Chou PH, Chen YL, Liu HC, Ko WC, Tsai PJ, Hung YP. The Role of Toll-Like Receptor-2 in Clostridioides difficile Infection: Evidence From a Mouse Model and Clinical Patients. Front Immunol 2021;12:691039. [PMID: 34322122 DOI: 10.3389/fimmu.2021.691039] [Reference Citation Analysis]
9 Khurana S, Kahl A, Yu K, DuPont AW. Recent advances in the treatment of Clostridioides difficile infection: the ever-changing guidelines. Fac Rev 2020;9:13. [PMID: 33659945 DOI: 10.12703/b/9-13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gotshal D, Azrad M, Hamo Z, Nitzan O, Peretz A. IL-16 and BCA-1 Serum Levels Are Associated with Disease Severity of C. difficile Infection. Pathogens 2021;10:631. [PMID: 34065379 DOI: 10.3390/pathogens10050631] [Reference Citation Analysis]
11 Chen Y, Huang K, Chen LK, Wu HY, Hsu CY, Tsai YS, Ko WC, Tsai PJ. Membrane Cholesterol Is Crucial for Clostridium difficile Surface Layer Protein Binding and Triggering Inflammasome Activation. Front Immunol 2020;11:1675. [PMID: 32849582 DOI: 10.3389/fimmu.2020.01675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]